PLK4 and cancer: Furthermore, Parsyan et al., observed that radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 exhibit a synergistic anti-cancer effect in TNBC patient-derived organoids [47].